
GHRH & GH Secretagogues
CJC-1295 no DAC
Buy 2, get 1 free10mg
$64.99
Welcome to VANTA LABS
Are you 21 or older?
Vanta Labs supplies research materials for laboratory use only. You must be 21 or older to enter.
Research use only. Not for human or veterinary use.

CJC-1295 + Ipamorelin is a research blend of a GHRH analog (CJC-1295) and a ghrelin-receptor peptide (Ipamorelin) offered by Vanta Labs as a lyophilized powder for laboratory and in-vitro research. Every batch is independently third-party tested and ships with a Certificate of Analysis confirming >=99% purity, with the lot number matched to its report. For laboratory research use only. Not for human or veterinary consumption; not a drug, food, cosmetic, or dietary supplement, and not intended to diagnose, treat, cure, or prevent any condition.
Purity
99.459%
Batch
Vanta184290
Published batch records
Vanta184290
10 mg · 99.459% · Aug 24, 2026 · Kovera Labs
Frequently Asked Questions
The No-DAC form, as named on the blend's own batch report. CJC-1295 exists in two chemically distinct versions with different molecular weights and reported half-lives, a longer-acting form carrying a Drug Affinity Complex (DAC) and a shorter-acting form without it (also called Modified GRF 1-29). This listing supplies the No-DAC form.
5 mg of Ipamorelin and 5 mg of CJC-1295 (No DAC), 10 mg in total, as named on the blend's own batch report.
It combines two peptides, CJC-1295 (No DAC) and Ipamorelin, supplied together in a single vial. CJC-1295 is a modified analog of growth hormone-releasing hormone (GHRH); Ipamorelin is a selective pentapeptide agonist of the ghrelin receptor (GHS-R). They are chemically unrelated compounds packaged together, not one novel molecule.
A blend has no single CAS number, molecular formula, or molecular weight; identity has to be assessed compound by compound. Ipamorelin's standalone identity (CAS 170851-70-4, C38H49N9O5, approximately 711.85 g/mol) is documented in public chemical databases. CJC-1295 (No DAC)'s standalone identity is not independently cited on this page, consistent with Vanta Labs' standalone CJC-1295 (No DAC) listing.
Vanta Labs publishes a batch-specific Certificate of Analysis for this blend, linked from the product page and searchable by batch number in the [COA Library](/coa-library).
Compare the lot or batch number printed on your vial label to the lot number listed on its Certificate of Analysis. See [How to Read a COA](/research/how-to-read-a-coa) for a walkthrough of what a Certificate of Analysis should show.
An HPLC (high-performance liquid chromatography) purity figure reports the proportion of a tested sample's mass attributable to the target compound in that specific run. It does not test stability, confirm biological activity, or guarantee that every vial from a production batch matches the tested sample. Purity and identity are separate questions; see the next entry.
Purity testing, commonly HPLC, measures how much of a sample's mass is the intended compound. Identity testing, commonly mass spectrometry, confirms that the molecule present actually matches its expected structure. A complete Certificate of Analysis documents both. See [Purity & Third-Party Testing](/research/purity-and-third-party-testing) for more on how the two differ.
Vanta Labs supplies CJC-1295 + Ipamorelin as a lyophilized powder in a single vial.
Follow the handling instructions printed on your own vial label and the linked Certificate of Analysis. See [Testing & Quality](/research/testing-and-quality) for Vanta Labs' general testing and handling overview.
Research use only (RUO) means the CJC-1295 + Ipamorelin blend is labeled, sold, and intended strictly for laboratory and in-vitro research by qualified personnel. It is not evaluated or approved by the FDA for human or veterinary use, is not a drug, dietary supplement, or cosmetic, and RUO labeling is not evidence that the product is safe or effective for any use outside the laboratory. See [Research Use Only](/research/research-use-only) for the full policy.
No. Neither is listed as an approved drug in the FDA's Drugs@FDA database. Both were previously nominated for Category 2 of the FDA's interim 503A Bulks List; both nominations were later withdrawn, and the FDA has since recommended against adding ipamorelin to that list. None of this represents FDA approval, clearance, or a safety finding.
The no-DAC form, as named on the blend's batch report. Ipamorelin is listed by PubChem under CAS 170851-70-4 (CID 9831659).
No. All compounds sold by Vanta Labs are strictly for legitimate laboratory research purposes and are not intended for human or veterinary use.
Where a batch report has been published, the product page links to it. All published reports are in the COA Library, searchable by batch number.
In-stock orders placed before 2PM ET on a business day are dispatched the same day. Carrier transit time is additional. You will receive secure tracking information after dispatch.
No — exactly one discount applies per order. Promo codes, ambassador codes, bundle pricing, and promotions never combine. You don't have to figure out which is best: checkout automatically applies whichever single discount saves you the most.
Where we ship, damaged or missing items, returns and support are covered in our FAQ.
Related Products
CJC-1295 + Ipamorelin combines two synthetic peptides commonly studied together in growth-hormone-axis (GHRH/GHS-R) research. Vanta Labs supplies this product as a single vial, with both components in one lyophilized fill.
CJC-1295 refers to a modified analog of growth hormone-releasing hormone, GHRH(1-29). The name covers two chemically distinct forms in the broader research-peptide literature: a shorter-acting version without a Drug Affinity Complex (also called Modified GRF 1-29, or No-DAC), and a longer-acting version carrying a DAC moiety that binds serum albumin. These two forms have different molecular weights and different reported half-lives. This blend's own batch report names the component CJC-1295 (No DAC), and Vanta Labs' standalone CJC-1295 (No DAC) product does not cite an independently verifiable public CAS number or formula for that specific form, so this listing follows the same practice rather than borrowing an identifier from the DAC form.
Ipamorelin is a synthetic pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) characterized in the literature as a selective agonist at the ghrelin/growth-hormone-secretagogue receptor (GHS-R). Its chemical identity, independent of this blend, is well documented: CAS 170851-70-4, molecular formula C38H49N9O5, molecular weight approximately 711.85 g/mol, as listed by PubChem (CID 9831659).
Because this product combines two chemically distinct peptides, no single CAS number, molecular formula, or molecular weight describes the blend as a whole. Each component carries its own identity, verifiable where a public record exists; Ipamorelin's standalone identity is documented in public chemical databases, while CJC-1295 (No DAC)'s is not independently cited here for the reason above.
This product is intended strictly for laboratory research by qualified personnel. It is not formulated, labeled, or sold for human consumption, veterinary use, or self-administration, and nothing in this listing should be read as dosing or administration guidance.
| Specification | Value |
|---|---|
| Product | CJC-1295 + Ipamorelin |
| Components | CJC-1295 (No DAC) + Ipamorelin |
| Labelled composition | 5 mg Ipamorelin, 5 mg CJC-1295 (No DAC), 10 mg total, as named on the blend's own batch report |
| CJC-1295 form | No DAC, as named on this blend's batch report |
| Ipamorelin CAS number | 170851-70-4 |
| Ipamorelin PubChem CID | 9831659 |
| Ipamorelin molecular formula | C38H49N9O5 |
| Ipamorelin molecular weight | approximately 711.85 g/mol |
| CJC-1295 (No DAC) CAS / formula / weight | Not independently cited here; see Product Details |
| Supplied form | Lyophilized powder |
| Package type | Single vial |
| Available size | 10 mg |
| Intended use | Laboratory research only (RUO) |
Specifications reflect the currently listed fill and may change if Vanta Labs updates the product's composition or size; always confirm against the live listing and the product's own Certificate of Analysis before relying on a specific figure.
A complete Certificate of Analysis (COA) for a peptide product typically documents two separate things: a purity figure, commonly from HPLC (high-performance liquid chromatography), and an identity confirmation, commonly from mass spectrometry. Purity testing reports what proportion of a sample's mass is the intended compound; identity testing confirms that the molecule present matches the expected structure. For a two-component blend, a purity figure is a blend-level result unless the report explicitly breaks it out by component.
Vanta Labs publishes a batch-specific Certificate of Analysis for this blend through the COA Library, covering the sample as submitted. Match the batch or lot number printed on your vial against the report linked from the product page before relying on a specific figure, and see How to Read a COA for a walkthrough of what the report shows.
No product-specific storage temperature or shelf-life figure beyond the product label is set out in this static section. Follow the handling instructions printed on your own vial and the linked Certificate of Analysis. General background on how Vanta Labs approaches testing and documentation is available at Testing & Quality, and on the distinction between purity and identity testing at Purity & Third-Party Testing.
This product is intended exclusively for in-vitro laboratory research by qualified personnel. It is not for human or veterinary use, consumption, diagnostic application, or clinical use of any kind, and nothing on this page should be interpreted as a recommendation for personal or self-administered use.
Neither CJC-1295 nor Ipamorelin is an FDA-approved drug. Both compounds were previously nominated for inclusion on the FDA's interim 503A Bulks List and were placed in Category 2; both nominations were later withdrawn, and the FDA removed both substances from Category 2 effective September 27, 2024. Following a subsequent advisory committee review on October 29, 2024, the FDA recommended against adding ipamorelin to the 503A Bulks List. Removal from Category 2 reflects a withdrawn nomination, not FDA approval, clearance, or a safety finding, and does not establish that either compound may be lawfully compounded or administered to humans or animals.
Full policy details are available at Research Use Only and the Research Use Disclaimer.
Blog
Store reviews · ordering, shipping and service
5.0 average customer rating
“Ordered on a Wednesday morning and wasn't expecting much because it was my first time buying here. Got tracking that afternoon and the package arrived Friday. Honestly faster than I expected lol.”
Vanta Labs customer
“Not gonna lie I accidentally added the wrong item to my cart and didn't realize until after checkout. Sent a message thinking I'd be stuck with it. Support helped me correct it before the package went out. Saved me a headache.”
Vanta Labs customer
“The packaging was actually what impressed me most. I've had glass research supplies arrive with barely any protection before, so seeing everything packed properly was a relief. Little things like that matter.”
Vanta Labs customer
“First time ordering here. The site was easy enough to use, although I had to go back and double check which size I selected. Everything was labeled clearly when it arrived.”
Vanta Labs customer
“Honestly I spent more time comparing options than I did checking out lol. Once I decided what I wanted, the actual order process took maybe two minutes.”
Vanta Labs customer
“Placed an order after a friend mentioned the website. I was a little skeptical because I hadn't heard of them before, but the ordering experience was straightforward and the communication was good. Everything came fast and will buy again.”
Vanta Labs customer
Sent to us by customers by email; names withheld. Reviews describe ordering, shipping and service.
Compound
Specifications
| Component | Labeled amount |
|---|---|
| Ipamorelin | 5 mg |
| CJC-1295 (No DAC) | 5 mg |
As labeled on batch report KVR-2026-6AA733.
Blend of two distinct peptides: CJC-1295 (No DAC), a modified GHRH(1-29) analog, as named on this blend's batch report, and Ipamorelin (Aib-His-D-2-Nal-D-Phe-Lys-NH2).This blend's batch report names the CJC-1295 component as the No-DAC form (also called Modified GRF 1-29), distinct from the longer-acting DAC form, which carries a different molecular weight. Vanta Labs' standalone CJC-1295 (No DAC) product does not cite an independently verifiable public CAS number or formula for that specific form, so none is assigned here either. Because the blend combines two distinct research peptides rather than one compound, it is not assigned a single shared CAS number or molecular weight; Ipamorelin's identifiers are listed separately above where they can be verified against public chemical databases.
Source: PubChem: Ipamorelin, CID 9831659 · FDA notice: removal of CJC-1295, ipamorelin acetate and others from Category 2 of the Interim 503A Bulks List · FDA Pharmacy Compounding Advisory Committee briefing/vote record, October 29, 2024, re: ipamorelin (free base) and ipamorelin acetate · Vanta Labs: CJC-1295 + Ipamorelin product page. Accessed 2026-11-10.
Testing
Certificates of Analysis for the batch currently supplied. Each report is the laboratory's own document for that vial size.
KVR-2026-6AA733 · 10 mg · Batch Vanta184290
Blend average purity 99.459% (RP-HPLC, C18 column, DAD detection at 214 nm) · Identity by LC-MS · Certified Aug 24, 2026 · Kovera Labs
Access code 3NQQ7E8
Kovera Labs reports can be checked with the laboratory: enter the report number and access code at koveralabs.com/verify.
Browse the COA LibraryOrdering: Shipping policy · Returns and reimbursement · Research use disclaimer